News | July 28, 2022
Velocity Clinical Research begins European expansion with German site acquisition
Biopharma and CROs to benefit from simplified access to global research sites
Biopharma and CROs to benefit from simplified access to global research sites
Addition of Pepscan with its peptide discovery, lead optimization and GMP manufacturing capabilities provides end-to-end offering to Biosynth Carbosynth’s peptide customers.
This investment will facilitate a Cipla entity's strategic participation in the Poe diagnostics and AMR space through the design, development, and manufacturing of microfluidics-based technologies
The company has a total sales of Rs. 25.8 crore during FY 21-22 and Rs. 26.4 crore during FY 20-21.
Wedgewood Pharmacy operates compounding pharmacies that offers sterile and non-sterile compounded medications for animal patients in 50 states.
The proposed combination involves corporate restructuring of JVCO, including through acquisition by Haleon via demerger
Operations at Oakville, Canada manufacturing plant expected to end by first quarter 2023
The acquisition will strengthen Lupin’s India formulation business by adding a fast-growing portfolio of vitamins, minerals, supplements and neurological products
Veritaz has over 40 brands marketed across the acute and critical care therapeutic segments
Casimir further differentiates Emmes’ industry-leading rare disease research capabilities
Subscribe To Our Newsletter & Stay Updated
